Clinical Trial Update: Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluate the efficacy and safety of Vivaglobin in previously untreated patients with primary immunodeficiency. The conditions include Comm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agammaglobulinemia
• Common Variable Immunodeficiency

Drugs mentioned

• Vivaglobin (immunoglobulin, human)

Snippet

Sponsor: CSL Behring | Conditions: Common Variable Immunodeficiency, Agammaglobulinemia | Phase 4 | Status: COMPLETED | Results posted: 2013-05-03